Providing comprehensive consulting services covering commercialization strategies for biopharma companies

- Managed 5 complex strategic alliances- Aligned internal activities across the drug development process for joint programs.- Initiated & led internal and joint strategic discussions regarding the alliances, including contracts amendments, to accommodate the business strategy. - Communicated Gilead needs & interests internally and externally while building & sustaining a collaborative relationship.- Anticipated & resolved alliances related internal & joint issues/risks to… Show more - Managed 5 complex strategic alliances- Aligned internal activities across the drug development process for joint programs.- Initiated & led internal and joint strategic discussions regarding the alliances, including contracts amendments, to accommodate the business strategy. - Communicated Gilead needs & interests internally and externally while building & sustaining a collaborative relationship.- Anticipated & resolved alliances related internal & joint issues/risks to prevent delays in deliverables.- Strategic advisor to internal alliance related functions/teams. Show less

- Led all aspects of active programs, from strategic decision making to day-to-day operations, working with cross functional teams.- Implemented search & evaluation activities soliciting potential projects across all biomedical fields.- Managed strategic alliances with the 3 founding institutions, with Novo Nordisk and with Deerfield Management Company.- Developed & maintained deep relationships with partners, ensuring alliances execution while coordinating resource allocation.

- Developing and commercializing biomedical inventions, technologies and programs.- Managed a dynamic portfolio of over 200 biomedical technologies across multiple therapeutic areas, prioritizing based on scientific & market due diligence.- Initiated & managed cross functional interactions between teams comprised of academic researchers, patent attorneys, biopharma scientists and business development professionals, and VCs.- Led the evaluation of over 400 early-stage projects for… Show more - Developing and commercializing biomedical inventions, technologies and programs.- Managed a dynamic portfolio of over 200 biomedical technologies across multiple therapeutic areas, prioritizing based on scientific & market due diligence.- Initiated & managed cross functional interactions between teams comprised of academic researchers, patent attorneys, biopharma scientists and business development professionals, and VCs.- Led the evaluation of over 400 early-stage projects for novelty & commercialization potential, resulting in over 200 patent applications.- Executed business development activities for over 350 technologies, leading to over 200 negotiations and over 150 contracts/agreements. Show less

Produced comprehensive reports covering commercialization strategies for start-up companies across all biomedical fields, resulting in successfully securing SBIR Phase II funding. Reports included market assessments & overview, competitive & IP landscape analyses, revenue projections, suggested strategies for market entry & potential commercialization partners interviews.

- Managed the strategic planning and operations of the startup.- Prepared and presented to company’s executives comprehensive market analysis of the drug repurposing field, including business strategy recommendations.- Supported program teams with my expertise in IP & commercialization competitive landscape analysis & market research.